Press Releases

Apr 7, 2026

Caleb Monroe

Press Releases

Fusion Fuel Announces Approximately $1.14 Million in New LPG Engineering Subcontracts Awarded to Al Shola Gas Across Multiple Projects in Dubai, UAE

Fusion Fuel Green PLC, via its subsidiary Al Shola Gas, has been awarded approximately $1.14 million in new LPG engineering subcontracts for multiple residential and mixed-use developments in Dubai, including a flagship dual-tower project valued at $0.5 million. These contracts support installation and commissioning of centralized LPG systems acros…

HTOO

Apr 7, 2026

Maya Rios

Press Releases

Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01

Evaxion A/S announced the completion of the one-year extension phase of its phase 2 trial for EVX-01, a personalized cancer vaccine developed with its AI-Immunology platform targeting advanced melanoma. Early trial results show a 75% objective response rate with durable clinical benefits and strong immune activation, underpinning the vaccine’s pote…

EVAX

Apr 7, 2026

Sofia Navarro

Press Releases

Enphase Energy Announces Conference Call to Review First Quarter 2026 Financial Results

Enphase Energy, a leader in solar microinverter technology and energy management systems, announced it will hold a conference call and webcast on April 28, 2026, to review its first quarter financial results ending March 31, 2026. The company highlighted its global footprint and innovation in solar energy solutions, with over 5.1 million systems de…

ENPH

Apr 7, 2026

Ajmal Hussain

Press Releases

Virtuix to Present at Exclusive Investor Forum at Mar-a-Lago Club in Palm Beach, Florida

Virtuix Inc. announced that CEO Jan Goetgeluk will present at a private investor forum at Mar-a-Lago and an investor lunch in West Palm Beach on April 16, 2026. The presentations will focus on Virtuix's expanding traction in the defense sector through sales and partnerships with the U.S. Army, Navy, and Marine Corps, its participation in Meta's 'Ma…

VTIX

Apr 7, 2026

Nina Shah

Press Releases

Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference

Anavex Life Sciences Corp., a Nasdaq-listed clinical-stage biopharmaceutical company, announced its upcoming presentation at the 25th Annual Needham Virtual Healthcare Conference, where its CEO and management team will discuss its pipeline of treatments targeting Alzheimer's, Parkinson's disease, Rett syndrome, and other CNS disorders. The company …

AVXL

Apr 7, 2026

Avery Klein

Press Releases

Bread Financial Schedules First Quarter 2026 Earnings Conference Call for Apr. 23

Bread Financial Holdings, a US-based tech-forward financial services company, has scheduled its first quarter 2026 earnings conference call for April 23, 2026. The company offers personalized payment, lending, and saving solutions, serving millions of consumers with co-brand, private label credit cards, and other financial products.

BFH

Apr 7, 2026

Jordan Park

Press Releases

Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit

Skye Bioscience, a clinical-stage biotech company, announced its upcoming presentation at the GLP-1-Based Therapeutics Summit. The company will showcase its development of nimacimab, a first-in-class, peripherally-restricted monoclonal antibody targeting the CB1 receptor to provide additive benefits to GLP-1 therapies for obesity and metabolic heal…

SKYE

Apr 7, 2026

Leila Farooq

Press Releases

AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly

AC Immune has amended its 2018 collaboration agreement with Eli Lilly to continue developing Morphomer® Tau aggregation inhibitors for Alzheimer's disease and other neurodegenerative conditions. The amendment reflects significant progress with Morphomer small molecules, adding new lead and backup candidates, and includes milestone payments totaling…

ACIU

Apr 7, 2026

Jordan Park

Press Releases

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences

MediWound Ltd. (Nasdaq: MDWD) announced presentations of new data on its enzymatic wound care product EscharEx at three leading wound care conferences in 2026. The data highlights EscharEx's unique mechanism of action, effective clinical performance in venous leg ulcers (VLUs), and its comparative advantages over the current standard, SANTYL. The f…

MDWD

Apr 7, 2026

Jordan Park

Press Releases

Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials

Fortrea has introduced Fortrea Intelligent Technology (FIT), a suite of AI-driven solutions designed to automate workflows, enhance oversight, and improve productivity in clinical trials. Built on the existing Xcellerate® platform, FIT provides near-real-time, persona-driven insights to sponsors, sites, and study teams, aiming to accelerate clinica…

FTRE

Apr 7, 2026

Jordan Park

Press Releases

Nurix Therapeutics to Participate in Upcoming Investor Conference

Nurix Therapeutics, a clinical-stage biopharmaceutical company specializing in targeted protein degradation medicines, announced that CEO Arthur Sands will participate in a fireside chat at the upcoming Needham Virtual Healthcare Conference. The company highlighted its current clinical and preclinical pipeline, including collaborations with major p…

NRIX

Apr 7, 2026

Nina Shah

Press Releases

Golar LNG Limited – Q1 2026 results presentation

Golar LNG Limited announced it will release its first-quarter 2026 financial results before market open on May 20, 2026, hosting a simultaneous webcast presentation and conference call for investors and analysts. This event will provide detailed insights into the company's recent performance, with opportunities for sell-side analysts to ask questio…

GLNG

Apr 7, 2026

Marcus Reed

Press Releases

Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial

Bluejay Diagnostics announced the successful enrollment of 624 patients in its SYMON-II pivotal clinical trial evaluating the Symphony IL-6 test for rapid sepsis triage and monitoring. The Company expects to complete enrollment soon, progressing toward clinical validation and FDA regulatory submission to bring its near-patient testing system to mar…

BJDX

Apr 7, 2026

Maya Rios

Press Releases

Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit

Serina Therapeutics presented innovative lipid nanoparticle (LNP) technology entirely built on its proprietary POZ Platform at the 5th LNP Formulation & Process Development Summit. This novel POZ-lipid avoids the immunogenic response seen with traditional PEG-lipids and targets safer ionizable lipids for oligonucleotide delivery. Early data highlig…

SER

Apr 7, 2026

Maya Rios

Press Releases

Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential

Greenwich LifeSciences announced new patent claims for their immunotherapy GLSI-100 based on statistically significant Phase III FLAMINGO-01 trial data showing clinically beneficial effects in a broader patient population. These claims could potentially double the market to 88,000 new patients annually in the US and Europe, projecting up to $10 bil…

GLSI

Apr 7, 2026

Nina Shah

Press Releases

Director/PDMR Shareholding

Shell plc disclosed that its Persons Discharging Managerial Responsibilities (PDMRs) have acquired dividend shares related to shares previously awarded under bonuses or employee share plans following the interim dividend payment on March 30, 2026. The acquisitions occurred across multiple exchanges and currencies, reflecting routine share plan acti…

SHEL

Apr 7, 2026

Nina Shah

Press Releases

Oculis to Participate in Upcoming Investor Conferences

Oculis Holding AG will participate in prominent investor conferences in April 2026, highlighting advancements in its late-stage ophthalmic and neuro-ophthalmic pipeline. Key upcoming milestones include Phase 3 pivotal results for OCS-01 in diabetic macular edema expected in June 2026, and late 2026 topline results for Licaminlimab in dry eye diseas…

OCS

Apr 7, 2026

Jordan Park

Press Releases

Pharming Group to participate in April investor conferences

Pharming Group N.V., a global biopharmaceutical company, announced that its management will participate and present at the 25th Annual Needham Virtual Healthcare Conference and the Van Lanschot Kempen Life Sciences Conference in April 2026. The presentations aim to update investors on company developments and facilitate meetings with investors and …

PHAR

Apr 6, 2026

Caleb Monroe

Press Releases

Xcel Brands, Inc. Announces Fourth Quarter Year-End 2025 Financial Results

Xcel Brands, Inc. announced its financial results for the fourth quarter and full year ending December 31, 2025. The company reported a net loss of $2.8 million for Q4 2025, improving from $7.1 million in the prior year quarter, and a full-year net loss of $17.5 million, down from $22.4 million in 2024. Adjusted EBITDA improved by 24% in Q4 and 35%…

XELB

Apr 6, 2026

Hana Yamamoto

Press Releases

NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update

NovaBridge Biosciences announced full-year 2025 financial results with strong cash reserves of $210.8 million supporting operations through 2028. The company highlighted successful transformation into a global biotech platform with two lead clinical programs: givastomig, targeting gastric cancer, and VIS-101, targeting wet age-related macular degen…

NBP

Apr 6, 2026

Maya Rios

Press Releases

Workhorse Launches Pricing Promotion on W56 Electric Step Vans

Workhorse Group Inc. has launched a promotional pricing campaign on its W56 electric step vans, offering price cuts of approximately $59,000 to $61,000 through September 2026. This move is designed to help commercial fleet operators manage soaring fuel expenses and accelerate the adoption of electric vehicles by leveraging operational efficiencies …

WKHS

Apr 6, 2026

Marcus Reed

Press Releases

SRx Health Solutions Returns +5.69% in March 2026 Driven by EMJX Artificial Intelligence (AI) Engine

SRx Health Solutions, trading on NYSE American as SRXH, announced a +5.69% return in March 2026 on its investment portfolio, outperforming the S&P 500's -4.98% decline. The gains were driven by the EMJX AI engine, part of SRx's upcoming merger with EMJ Crypto Technologies. The Board is considering implementing a quarterly dividend policy based on p…

SRXH

Apr 6, 2026

Sofia Navarro

Press Releases

Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System

Treace Medical Concepts has completed the first surgical cases using its new SuperBite™ Compression Screw System designed for bunion and midfoot deformity surgeries. The system offers advanced compression technologies and versatile screw sizes to address a wide range of foot and ankle procedures. Full commercialization is expected in Q3 2026, along…

TMCI

Apr 6, 2026

Priya Menon

Press Releases

Bath & Body Works Celebrates 20 Years of Japanese Cherry Blossom: An Elevated Fragrance Icon

Bath & Body Works celebrates the 20th anniversary of its iconic Japanese Cherry Blossom fragrance, which has generated over $1.5 billion in lifetime sales globally. To commemorate the milestone, the company introduced a new complementary fragrance called Forever Cherry Blossom and reintroduced an early 2000s favorite Cherry Blossom scent. These ini…

BBW

Apr 6, 2026

Caleb Monroe

Press Releases

New Research Reveals Busy Is Not the Same as Profitable for Commercial Landscaping Contractors in 2026

Aspire Software, a subsidiary of ServiceTitan (Nasdaq: TTAN), released its 2026 Landscaping Technology Trends Report revealing that while 59% of commercial landscaping contractors aim to increase revenue, nearly half prioritize improving profit margins. The report emphasizes that contractors leveraging deeply integrated software platforms demonstra…

TTAN